![](/img/cover-not-exists.png)
Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study
Du, Xin, Lai, Yue-Yun, Xiao, Zhijian, Liu, Ting, Hu, Yu, Sun, Aining, Li, Xiao, Shen, Zhi-Xiang, Jin, Jie, Yu, Li, Laille, Eric, Dong, Qian, Songer, Stephen, Beach, C.L.Language:
english
Journal:
Asia-Pacific Journal of Clinical Oncology
DOI:
10.1111/ajco.12835
Date:
December, 2017
File:
PDF, 350 KB
english, 2017